Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Curegenetics Raises $17m In Series A Financing
Venture Capital

Curegenetics Raises $17m In Series A Financing

by vcaonline.com posted 11months ago 36 views
CureGenetics raises $17 million in Series A Financing SUZHOU, China, August 6, 2018-- Cure Genetics Co., Ltd ("CureGenetics"), a biotechnology company dedicated to the development of life-saving transformative medicines and molecular diagnostics using best-in-class gene editing technologies, announced the closing of $17 million Series A financing, led by Qiming Venture Partners. Additional investors included CTS Capital and Ascendin Investment. The company intends to use the proceeds to further optimize its gene editing and delivery platform, to sponsor IND application and clinical trials, and to develop its diverse pipelines.

In this article